Response of Metabolic Syndrome and Sexual Dysfunction to Lifestyle Changes in Men With Psoriasis

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05632042
Collaborator
(none)
60
1
2
6
10

Study Details

Study Description

Brief Summary

complaint of sexual dysfunction and metabolic syndrome are highly reported in men with psoriasis

Condition or Disease Intervention/Treatment Phase
  • Behavioral: lifestyle modification (exercise and control of diet)
N/A

Detailed Description

erectile dysfunction (ED) psoriatic men with metabolic syndrome (number of the patients will be 60) will assigned to study group (group = 30 patients) that will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week) or control group (group=30 patients) that will receive no lifestyle changes/modifications.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Response of Metabolic Syndrome and Sexual Dysfunction to Lifestyle Changes/Modifications in Men With Psoriasis
Actual Study Start Date :
Oct 16, 2022
Anticipated Primary Completion Date :
Apr 16, 2023
Anticipated Study Completion Date :
Apr 16, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: lifestyle-modification group

erectile dysfunction (ED) psoriatic men with metabolic syndrome (group = 30 patients) will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week)

Behavioral: lifestyle modification (exercise and control of diet)
erectile dysfunction (ED) psoriatic men with metabolic syndrome that will receive lifestyle changes (12 weeks of low calorie diet and moderate-intensity walking on treadmill, the walking duration will be 40 minutes, the walking will be three times per week)

No Intervention: control group

erectile dysfunction (ED) psoriatic men with metabolic syndrome (number of the patients will be 30) that will receive no lifestyle changes/modifications.

Outcome Measures

Primary Outcome Measures

  1. International Index of Erectile Function [It will be measured after 12-week intervention]

    Arabic version of this 5-item questionnaire will used to assess erectile function/dysfunction

Secondary Outcome Measures

  1. psoriasis area and severity index [It will be measured after 12-week intervention]

    it is a tool used to measure the severity and extent of psoriasis.

  2. body mass index [It will be measured after 12-week intervention]

    patients will be assessed with empty bowel and bladder

  3. systolic blood pressure [It will be measured after 12-week intervention]

    it will be measured using sphygmomanometer

  4. diastolic blood presure [It will be measured after 12-week intervention]

    it will be measured using sphygmomanometer

  5. waist circumference [It will be measured after 12-week intervention]

    it will be measured by in elastic tape

  6. blood glucose [It will be measured after 12-week intervention]

    it will be measured in fasting status

  7. triglycerides [It will be measured after 12-week intervention]

    it will be measured in serum

  8. high density lipoprotein [It will be measured after 12-week intervention]

    it will be measured in serum

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 45 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • psoriatic married men with metabolic syndrome and erectile dysfunction
Exclusion Criteria:
  • patients with heart, respiratory, other autoimmune problems

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cairo Unoversity Giza Egypt

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: Ali Ismail, lecturer, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ali Mohamed Ali ismail, lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University, Cairo University
ClinicalTrials.gov Identifier:
NCT05632042
Other Study ID Numbers:
  • P.T.REC/012/004117
First Posted:
Nov 30, 2022
Last Update Posted:
Nov 30, 2022
Last Verified:
Nov 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 30, 2022